Nurix Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Nurix Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Nurix Therapeutics Inc
Rating: 1.65641675
Author: Trendlyne DVM scores

about

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

9.76 -1.10 (-10.13%)

66.98% Fall from 52W High

2.0M

XNAS Volume

XNAS 10 Oct, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Nurix Therapeutics Inc took place on 10 Oct 2025, for the purpose of Nurix Therapeutics Inc Third Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

19.2 / 100

Technically Neutral

47.1 / 100

1Yr Price target upside is 210%

17 analysts

Nurix Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nurix Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

66.98% Fall from 52W High

SWOT Analysis

Nurix Therapeutics Inc Live Price Chart